COL6A1 and cancer: In colitis-associated cancer (CAC) models, mice with Col6a1+ fibroblast-specific deletion of Stat3 or Ikbkb (but not Tlr4 or Myd88) demonstrate reduced cancer development (10, 118, 123, 124).